vimarsana.com

Latest Breaking News On - Vicore pharma - Page 1 : vimarsana.com

Vicore Pharma Holding: Increase of Number of Shares and Votes in Vicore Pharma

STOCKHOLM, SE / ACCESSWIRE / May 31, 2024 / Vicore Pharma Holding (STO:VICO) Stockholm, May 31, 2024 - Vicore Pharma Holding AB (STO: VICO) ("Vicore") announced today that the number of Vicore shares and

Increase of Number of Shares and Votes in Vicore Pharma

Increase of Number of Shares and Votes in Vicore Pharma
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improv

STOCKHOLM, SWEDEN / ACCESSWIRE / May 20, 2024 / Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis reflected an increase in.

Vicore s IPF drug improves lung function in phase 2 win

Vicore s IPF drug improves lung function in phase 2 win
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Vicore and Endeavor s therapies show promise in treating IPF

Both drugs have the potential to offer a disease-modifying approach to the lung disease

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.